Subject: Re: pharma patents starting to look like software...
From: Laurent GUERBY <>
Date: Wed, 02 Feb 2005 19:55:08 +0100

On Wed, 2005-02-02 at 10:34 -0500, Chris Maeda wrote:
> According to this article, IP in the pharma industry is starting to
> have some of the same problems as the software industry; i.e. the cost
> of licensing multiple patents is making some new product development
> too expensive.

>From the tone of the article, I guess they're talking about
the extreme difficulty of licensing 2 to 5 patents instead
of just making a one-patent product.

I guess they haven't looked at software patents yet...
"an estimated 150,000 to 300,000 registered software patents in the US"